An observational study in Macular Degeneration Choroidal Neovascularization, sponsored by Federico II University. Completed at 1 site in Italy. Open to participants aged 50 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-22.
Sponsored by Federico II University · Observational
To evaluate the activity of neovascular macula degeneretion as assessed by SD-OCTand OCT-A using a split-person study design and deep-learning quantification.
Exudative neovascular macular degeneration is the primarily an age-related retinal condition The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features in order to choose the best therapy .
The study evaluates the changes in structural optical coherence tomography and optical coherence tomography angiography features in neovascular macular degeration patients undergoing ANTI-VEGF treatments using artificial intelligence.
214 studies on the registry are indexed under Choroidal Neovascularization; 12 are open to participants now.
This study's enrollment of 50 is below the median of 79 across 42 observational studies indexed under Choroidal Neovascularization.
Browse Choroidal Neovascularization studies →Federico II University is the lead sponsor of 366 studies on the registry; 61 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The participans were older than 50 years with diagnosis of neovascular macular degeneration. They did not present other ophthalmological disease
Inclusion Criteria: age older than 50 years
Exclusion Criteria:• age younger than 50 years
Diagnostic Test: Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter
Diagnostic Test: Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter
Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter before and after ANTI-VEGF treatment
The measurements of retinal and choriocapillary vessel density in patients with macular degeneration complicated by nvc
Time frame: more than sixmonths
Ran from Jul 2023 to primary completion in Jul 2023, 0 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Choroidal Neovascularization →